Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 227 entries
Sorted by: Best Match Show Resources per page
Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers.

Journal of radiosurgery and SBRT

Braunstein SE, Dionisio SA, Lometti MW, Pinnaduwage DS, Chuang CF, Yom SS, Gottschalk AR, Descovich M.
PMID: 29296387
J Radiosurg SBRT. 2014;3(1):67-79.

PURPOSE/OBJECTIVE: Dose calculation in treatment planning must account for tissue heterogeneity, especially for tumors within low-density lung tissues. While Monte Carlo (MC) calculation methods are the most accurate, Ray Tracing (RT) methods are also commonly employed. We evaluated dose...

Cite
Braunstein SE, Dionisio SA, Lometti MW, et al. Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers. J Radiosurg SBRT. 2014;3(1):67-79
Braunstein, S. E., Dionisio, S. A., Lometti, M. W., Pinnaduwage, D. S., Chuang, C. F., Yom, S. S., Gottschalk, A. R., & Descovich, M. (2014). Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers. Journal of radiosurgery and SBRT, 3(1), 67-79.
Braunstein, Steve E, et al. "Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers." Journal of radiosurgery and SBRT vol. 3,1 (2014): 67-79.
Braunstein SE, Dionisio SA, Lometti MW, Pinnaduwage DS, Chuang CF, Yom SS, Gottschalk AR, Descovich M. Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers. J Radiosurg SBRT. 2014;3(1):67-79. PMID: 29296387; PMCID: PMC5725332.
Copy Download .nbib Format: NLM
Degenerate parametric amplifiers with a squeezed pump.

Physical review. A, Atomic, molecular, and optical physics

Braunstein SL, Cohen N.
PMID: 9912305
Phys Rev A. 1995 Jul;52(1):815-829. doi: 10.1103/physreva.52.815.

No abstract available.

Cite
Braunstein SL, Cohen N. Degenerate parametric amplifiers with a squeezed pump. Phys Rev A. 1995;52(1):815-829doi: 10.1103/physreva.52.815.
Braunstein, S. L., & Cohen, N. (1995). Degenerate parametric amplifiers with a squeezed pump. Physical review. A, Atomic, molecular, and optical physics, 52(1), 815-829. https://doi.org/10.1103/physreva.52.815
Braunstein, and Cohen. "Degenerate parametric amplifiers with a squeezed pump." Physical review. A, Atomic, molecular, and optical physics vol. 52,1 (1995): 815-829. doi: https://doi.org/10.1103/physreva.52.815
Braunstein SL, Cohen N. Degenerate parametric amplifiers with a squeezed pump. Phys Rev A. 1995 Jul;52(1):815-829. doi: 10.1103/physreva.52.815. PMID: 9912305.
Copy Download .nbib Format: NLM
Limitations to squeezing in a parametric amplifier due to pump quantum fluctuations.

Physical review. A, General physics

Braunstein SL, Crouch DD.
PMID: 9900936
Phys Rev A Gen Phys. 1988 Nov 01;38(9):4696-4711. doi: 10.1103/physreva.38.4696.

No abstract available.

Cite
Braunstein SL, Crouch DD. Limitations to squeezing in a parametric amplifier due to pump quantum fluctuations. Phys Rev A Gen Phys. 1988;38(9):4696-4711doi: 10.1103/physreva.38.4696.
Braunstein, S. L., & Crouch, D. D. (1988). Limitations to squeezing in a parametric amplifier due to pump quantum fluctuations. Physical review. A, General physics, 38(9), 4696-4711. https://doi.org/10.1103/physreva.38.4696
Braunstein, and Crouch. "Limitations to squeezing in a parametric amplifier due to pump quantum fluctuations." Physical review. A, General physics vol. 38,9 (1988): 4696-4711. doi: https://doi.org/10.1103/physreva.38.4696
Braunstein SL, Crouch DD. Limitations to squeezing in a parametric amplifier due to pump quantum fluctuations. Phys Rev A Gen Phys. 1988 Nov 01;38(9):4696-4711. doi: 10.1103/physreva.38.4696. PMID: 9900936.
Copy Download .nbib Format: NLM
Homodyne statistics.

Physical review. A, Atomic, molecular, and optical physics

Braunstein SL.
PMID: 9903824
Phys Rev A. 1990 Jul 01;42(1):474-481. doi: 10.1103/physreva.42.474.

No abstract available.

Cite
Braunstein SL. Homodyne statistics. Phys Rev A. 1990;42(1):474-481doi: 10.1103/physreva.42.474.
Braunstein, S. L. (1990). Homodyne statistics. Physical review. A, Atomic, molecular, and optical physics, 42(1), 474-481. https://doi.org/10.1103/physreva.42.474
Braunstein. "Homodyne statistics." Physical review. A, Atomic, molecular, and optical physics vol. 42,1 (1990): 474-481. doi: https://doi.org/10.1103/physreva.42.474
Braunstein SL. Homodyne statistics. Phys Rev A. 1990 Jul 01;42(1):474-481. doi: 10.1103/physreva.42.474. PMID: 9903824.
Copy Download .nbib Format: NLM
Complete spin-transfer measurements for inelastic polarized proton scattering from 12C.

Physical review. C, Nuclear physics

Bacher AD, Braunstein MR, Carey TA, Chen XY, Jones KW, McClelland JB, Rees L, Shepard JR, Taddeucci TN, Tanaka N.
PMID: 9967627
Phys Rev C Nucl Phys. 1991 Nov;44(5):2041-2052. doi: 10.1103/physrevc.44.2041.

No abstract available.

Cite
Bacher AD, Braunstein MR, Carey TA, et al. Complete spin-transfer measurements for inelastic polarized proton scattering from 12C. Phys Rev C Nucl Phys. 1991;44(5):2041-2052doi: 10.1103/physrevc.44.2041.
Bacher, A. D., Braunstein, M. R., Carey, T. A., Chen, X. Y., Jones, K. W., McClelland, J. B., Rees, L., Shepard, J. R., Taddeucci, T. N., & Tanaka, N. (1991). Complete spin-transfer measurements for inelastic polarized proton scattering from 12C. Physical review. C, Nuclear physics, 44(5), 2041-2052. https://doi.org/10.1103/physrevc.44.2041
Bacher, et al. "Complete spin-transfer measurements for inelastic polarized proton scattering from 12C." Physical review. C, Nuclear physics vol. 44,5 (1991): 2041-2052. doi: https://doi.org/10.1103/physrevc.44.2041
Bacher AD, Braunstein MR, Carey TA, Chen XY, Jones KW, McClelland JB, Rees L, Shepard JR, Taddeucci TN, Tanaka N. Complete spin-transfer measurements for inelastic polarized proton scattering from 12C. Phys Rev C Nucl Phys. 1991 Nov;44(5):2041-2052. doi: 10.1103/physrevc.44.2041. PMID: 9967627.
Copy Download .nbib Format: NLM
Nucleation model for multiparticle reactions with finite reaction rates in one dimension.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics

Braunstein LA, Buceta RC.
PMID: 9965831
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1996 Dec;54(6):6125-6127. doi: 10.1103/physreve.54.6125.

No abstract available.

Cite
Braunstein LA, Buceta RC. Nucleation model for multiparticle reactions with finite reaction rates in one dimension. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1996;54(6):6125-6127doi: 10.1103/physreve.54.6125.
Braunstein, L. A., & Buceta, R. C. (1996). Nucleation model for multiparticle reactions with finite reaction rates in one dimension. Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 54(6), 6125-6127. https://doi.org/10.1103/physreve.54.6125
Braunstein, and Buceta. "Nucleation model for multiparticle reactions with finite reaction rates in one dimension." Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics vol. 54,6 (1996): 6125-6127. doi: https://doi.org/10.1103/physreve.54.6125
Braunstein LA, Buceta RC. Nucleation model for multiparticle reactions with finite reaction rates in one dimension. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1996 Dec;54(6):6125-6127. doi: 10.1103/physreve.54.6125. PMID: 9965831.
Copy Download .nbib Format: NLM
Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer.

International journal of radiation oncology, biology, physics

Lapen K, Sabol C, Tin AL, Lynch K, Kassa A, Mabli X, Ford J, Cha E, Bernstein MB, Braunstein LZ, Cahlon O, Daly BM, Sandler K, McCloskey SA, Vickers AJ, Khan AJ, Gillespie EF.
PMID: 34314814
Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):979-991. doi: 10.1016/j.ijrobp.2021.07.1692. Epub 2021 Jul 24.

PURPOSE: We aimed to develop and study the implementation of a remote system for toxicity assessment and management of acute side effects of breast radiation using electronic patient-reported outcomes (ePROs).METHODS AND MATERIALS: A response-adapted Patient-Reported Outcomes Common Terminology Criteria...

Cite
Lapen K, Sabol C, Tin AL, et al. Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2021;111(4):979-991doi: 10.1016/j.ijrobp.2021.07.1692.
Lapen, K., Sabol, C., Tin, A. L., Lynch, K., Kassa, A., Mabli, X., Ford, J., Cha, E., Bernstein, M. B., Braunstein, L. Z., Cahlon, O., Daly, B. M., Sandler, K., McCloskey, S. A., Vickers, A. J., Khan, A. J., & Gillespie, E. F. (2021). Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer. International journal of radiation oncology, biology, physics, 111(4), 979-991. https://doi.org/10.1016/j.ijrobp.2021.07.1692
Lapen, Kaitlyn, et al. "Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer." International journal of radiation oncology, biology, physics vol. 111,4 (2021): 979-991. doi: https://doi.org/10.1016/j.ijrobp.2021.07.1692
Lapen K, Sabol C, Tin AL, Lynch K, Kassa A, Mabli X, Ford J, Cha E, Bernstein MB, Braunstein LZ, Cahlon O, Daly BM, Sandler K, McCloskey SA, Vickers AJ, Khan AJ, Gillespie EF. Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):979-991. doi: 10.1016/j.ijrobp.2021.07.1692. Epub 2021 Jul 24. PMID: 34314814; PMCID: PMC8530913.
Copy Download .nbib Format: NLM
Compassionate Use of REGEN-COV ® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Stein D, Oviedo-Orta E, Kampman WA, McGinniss J, Betts G, McDermott M, Holly B, Lancaster JM, Braunstein N, Yancopoulos GD, Weinreich DM.
PMID: 34971385
Clin Infect Dis. 2021 Dec 31; doi: 10.1093/cid/ciab1059. Epub 2021 Dec 31.

BACKGROUND: Patients with immunodeficiency-associated antibody disorders are at a higher risk of prolonged/persistent COVID-19 infection, having no viable treatment options.METHODS: A retrospective analysis of patients with primary and/or secondary immunodeficiency-associated antibody disorders who received casirivimab and imdevimab (REGEN-COV ®)...

Cite
Stein D, Oviedo-Orta E, Kampman WA, et al. Compassionate Use of REGEN-COV ® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab1059.
Stein, D., Oviedo-Orta, E., Kampman, W. A., McGinniss, J., Betts, G., McDermott, M., Holly, B., Lancaster, J. M., Braunstein, N., Yancopoulos, G. D., & Weinreich, D. M. (2021). Compassionate Use of REGEN-COV ® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab1059
Stein, David, et al. "Compassionate Use of REGEN-COV ® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab1059
Stein D, Oviedo-Orta E, Kampman WA, McGinniss J, Betts G, McDermott M, Holly B, Lancaster JM, Braunstein N, Yancopoulos GD, Weinreich DM. Compassionate Use of REGEN-COV ® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders. Clin Infect Dis. 2021 Dec 31; doi: 10.1093/cid/ciab1059. Epub 2021 Dec 31. PMID: 34971385; PMCID: PMC8755381.
Copy Download .nbib Format: NLM
Subcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection.

medRxiv : the preprint server for health sciences

O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM.
PMID: 34159343
medRxiv. 2021 Jun 14; doi: 10.1101/2021.06.14.21258569.

BACKGROUND: Casirivimab and imdevimab administered together (REGEN-COV™) markedly reduces the risk of hospitalization or death in high-risk, symptomatic individuals with COVID-19. Here, we report phase 3 results of early treatment of asymptomatic, SARS-CoV-2-positive adults and adolescents with subcutaneous REGEN-COV.METHODS:...

Cite
O'Brien MP, Forleo-Neto E, Sarkar N, et al. Subcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection. medRxiv. 2021;doi: 10.1101/2021.06.14.21258569.
O'Brien, M. P., Forleo-Neto, E., Sarkar, N., Isa, F., Hou, P., Chan, K. C., Musser, B. J., Bar, K. J., Barnabas, R. V., Barouch, D. H., Cohen, M. S., Hurt, C. B., Burwen, D. R., Marovich, M. A., Heirman, I., Davis, J. D., Turner, K. C., Ramesh, D., Mahmood, A., Hooper, A. T., Hamilton, J. D., Kim, Y., Purcell, L. A., Baum, A., Kyratsous, C. A., Krainson, J., Perez-Perez, R., Mohseni, R., Kowal, B., DiCioccio, A. T., Stahl, N., Lipsich, L., Braunstein, N., Herman, G., Yancopoulos, G. D., & Weinreich, D. M. (2021). Subcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.06.14.21258569
O'Brien, Meagan P, et al. "Subcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.06.14.21258569
O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM. Subcutaneous REGEN-COV Antibody Combination in Early SARS-CoV-2 Infection. medRxiv. 2021 Jun 14; doi: 10.1101/2021.06.14.21258569. PMID: 34159343; PMCID: PMC8219113.
Copy Download .nbib Format: NLM
Association of mental health diagnosis with race and all-cause mortality after a cancer diagnosis: Large-scale analysis of electronic health record data.

Cancer

Chen WC, Boreta L, Braunstein SE, Rabow MW, Kaplan LE, Tenenbaum JD, Morin O, Park CC, Hong JC.
PMID: 34550601
Cancer. 2022 Jan 15;128(2):344-352. doi: 10.1002/cncr.33903. Epub 2021 Sep 22.

BACKGROUND: Disparity in mental health care among cancer patients remains understudied.METHODS: A large, retrospective, single tertiary-care institution cohort study was conducted based on deidentified electronic health record data of 54,852 adult cancer patients without prior mental health diagnosis (MHD)...

Cite
Chen WC, Boreta L, Braunstein SE, et al. Association of mental health diagnosis with race and all-cause mortality after a cancer diagnosis: Large-scale analysis of electronic health record data. Cancer. 2021;128(2):344-352doi: 10.1002/cncr.33903.
Chen, W. C., Boreta, L., Braunstein, S. E., Rabow, M. W., Kaplan, L. E., Tenenbaum, J. D., Morin, O., Park, C. C., & Hong, J. C. (2022). Association of mental health diagnosis with race and all-cause mortality after a cancer diagnosis: Large-scale analysis of electronic health record data. Cancer, 128(2), 344-352. https://doi.org/10.1002/cncr.33903
Chen, William C, et al. "Association of mental health diagnosis with race and all-cause mortality after a cancer diagnosis: Large-scale analysis of electronic health record data." Cancer vol. 128,2 (2022): 344-352. doi: https://doi.org/10.1002/cncr.33903
Chen WC, Boreta L, Braunstein SE, Rabow MW, Kaplan LE, Tenenbaum JD, Morin O, Park CC, Hong JC. Association of mental health diagnosis with race and all-cause mortality after a cancer diagnosis: Large-scale analysis of electronic health record data. Cancer. 2022 Jan 15;128(2):344-352. doi: 10.1002/cncr.33903. Epub 2021 Sep 22. PMID: 34550601.
Copy Download .nbib Format: NLM
Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Choi JI, Khan AJ, Powell SN, McCormick B, Lozano AJ, Del Rosario G, Mamary J, Liu H, Fox P, Gillespie E, Braunstein LZ, Mah D, Cahlon O.
PMID: 34688807
Radiother Oncol. 2021 Dec;165:142-151. doi: 10.1016/j.radonc.2021.10.010. Epub 2021 Oct 22.

BACKGROUND AND PURPOSE: Late local recurrences and second primary breast cancers are increasingly common. Proton beam therapy (PBT) reirradiation (reRT) may allow safer delivery of a second definitive radiotherapy (RT) course. We analyzed outcomes of patients with recurrent or...

Cite
Choi JI, Khan AJ, Powell SN, et al. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation. Radiother Oncol. 2021;165:142-151doi: 10.1016/j.radonc.2021.10.010.
Choi, J. I., Khan, A. J., Powell, S. N., McCormick, B., Lozano, A. J., Del Rosario, G., Mamary, J., Liu, H., Fox, P., Gillespie, E., Braunstein, L. Z., Mah, D., & Cahlon, O. (2021). Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 165142-151. https://doi.org/10.1016/j.radonc.2021.10.010
Choi, J Isabelle, et al. "Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 165 (2021): 142-151. doi: https://doi.org/10.1016/j.radonc.2021.10.010
Choi JI, Khan AJ, Powell SN, McCormick B, Lozano AJ, Del Rosario G, Mamary J, Liu H, Fox P, Gillespie E, Braunstein LZ, Mah D, Cahlon O. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation. Radiother Oncol. 2021 Dec;165:142-151. doi: 10.1016/j.radonc.2021.10.010. Epub 2021 Oct 22. PMID: 34688807.
Copy Download .nbib Format: NLM
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis.

Molecular neurodegeneration

West T, Kirmess KM, Meyer MR, Holubasch MS, Knapik SS, Hu Y, Contois JH, Jackson EN, Harpstrite SE, Bateman RJ, Holtzman DM, Verghese PB, Fogelman I, Braunstein JB, Yarasheski KE.
PMID: 33933117
Mol Neurodegener. 2021 May 01;16(1):30. doi: 10.1186/s13024-021-00451-6.

BACKGROUND: The development of blood-based biomarker tests that are accurate and robust for Alzheimer's disease (AD) pathology have the potential to aid clinical diagnosis and facilitate enrollment in AD drug trials. We developed a high-resolution mass spectrometry (MS)-based test...

Cite
West T, Kirmess KM, Meyer MR, et al. A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis. Mol Neurodegener. 2021;16(1):30doi: 10.1186/s13024-021-00451-6.
West, T., Kirmess, K. M., Meyer, M. R., Holubasch, M. S., Knapik, S. S., Hu, Y., Contois, J. H., Jackson, E. N., Harpstrite, S. E., Bateman, R. J., Holtzman, D. M., Verghese, P. B., Fogelman, I., Braunstein, J. B., & Yarasheski, K. E. (2021). A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis. Molecular neurodegeneration, 16(1), 30. https://doi.org/10.1186/s13024-021-00451-6
West, Tim, et al. "A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis." Molecular neurodegeneration vol. 16,1 (2021): 30. doi: https://doi.org/10.1186/s13024-021-00451-6
West T, Kirmess KM, Meyer MR, Holubasch MS, Knapik SS, Hu Y, Contois JH, Jackson EN, Harpstrite SE, Bateman RJ, Holtzman DM, Verghese PB, Fogelman I, Braunstein JB, Yarasheski KE. A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis. Mol Neurodegener. 2021 May 01;16(1):30. doi: 10.1186/s13024-021-00451-6. PMID: 33933117; PMCID: PMC8088704.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 227 entries